Goal templates — Pharmacovigilance (Drug Safety) — P6
Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) · P6 — Principal Professional
These are canon-derived frames, not advice: every line is either verbatim JobFrame canon text or a fixed template wrapping it. ⟨target⟩ / ⟨baseline⟩ / ⟨date⟩ are placeholders for the manager to fill in. Nothing here is generated by AI — rows are omitted, never invented, when the canon lacks the underlying field.
SMART goals
One row per canon core output / responsibility this level owns.
JFM responsibility (P6)
Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability)
- Specific
- Deliver: "Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability)"
- Measurable
- Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
- Achievable
- Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system."
- Relevant
- Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional.
- Time-bound
- ⟨date⟩
JFM responsibility (P6)
Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system
- Specific
- Deliver: "Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system"
- Measurable
- Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
- Achievable
- Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system."
- Relevant
- Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional.
- Time-bound
- ⟨date⟩
JFM responsibility (P6)
Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations
- Specific
- Deliver: "Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations"
- Measurable
- Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
- Achievable
- Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system."
- Relevant
- Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional.
- Time-bound
- ⟨date⟩
JFM responsibility (P6)
Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge
- Specific
- Deliver: "Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge"
- Measurable
- Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
- Achievable
- Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system."
- Relevant
- Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional.
- Time-bound
- ⟨date⟩
JFM responsibility (P6)
Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice
- Specific
- Deliver: "Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice"
- Measurable
- Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩.
- Achievable
- Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system."
- Relevant
- Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional.
- Time-bound
- ⟨date⟩
Copy / print as textshow ▾hide ▴
1. Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability) [source: JFM responsibility (P6)] Specific: Deliver: "Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability)" Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩. Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system." Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional. Time-bound: ⟨date⟩ 2. Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system [source: JFM responsibility (P6)] Specific: Deliver: "Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system" Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩. Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system." Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional. Time-bound: ⟨date⟩ 3. Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations [source: JFM responsibility (P6)] Specific: Deliver: "Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations" Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩. Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system." Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional. Time-bound: ⟨date⟩ 4. Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge [source: JFM responsibility (P6)] Specific: Deliver: "Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge" Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩. Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system." Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional. Time-bound: ⟨date⟩ 5. Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice [source: JFM responsibility (P6)] Specific: Deliver: "Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice" Measurable: Move the metric this drives from ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩. Achievable: Scoped to this level's jfm complexity/problem-solving rubric: "Leads visionary, system-level problem-solving on critical safety escalations, with full latitude and ultimate accountability for the PV system." Relevant: Advances the Pharmacovigilance (Drug Safety) · Pharmacovigilance (Drug Safety) mandate for a P6 — Principal Professional. Time-bound: ⟨date⟩
OKRs
Objectives from this level's core outputs; key results only where a real dimension or capability backs them.
JFM responsibility (P6)
Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability)
- From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability)"
- Evidence at this level's scope bar: "Organization-wide architecture and the hardest problems" — ⟨target⟩ by ⟨date⟩
JFM responsibility (P6)
Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system
- From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system"
- Evidence at this level's autonomy bar: "Defines direction; minimal oversight" — ⟨target⟩ by ⟨date⟩
JFM responsibility (P6)
Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations
- From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations"
- Evidence at this level's complexity bar: "Strategic, open-ended problems shaping the technical future" — ⟨target⟩ by ⟨date⟩
JFM responsibility (P6)
Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge
- From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge"
- Evidence at this level's impact bar: "Organization-wide" — ⟨target⟩ by ⟨date⟩
JFM responsibility (P6)
Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice
- From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice"
- Evidence at this level's decision rights bar: "Sets technical strategy for a major area" — ⟨target⟩ by ⟨date⟩
Copy / print as textshow ▾hide ▴
Objective 1: Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability) [source: JFM responsibility (P6)] KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability)" KR2. Evidence at this level's scope bar: "Organization-wide architecture and the hardest problems" — ⟨target⟩ by ⟨date⟩ Objective 2: Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system [source: JFM responsibility (P6)] KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system" KR2. Evidence at this level's autonomy bar: "Defines direction; minimal oversight" — ⟨target⟩ by ⟨date⟩ Objective 3: Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations [source: JFM responsibility (P6)] KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations" KR2. Evidence at this level's complexity bar: "Strategic, open-ended problems shaping the technical future" — ⟨target⟩ by ⟨date⟩ Objective 4: Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge [source: JFM responsibility (P6)] KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge" KR2. Evidence at this level's impact bar: "Organization-wide" — ⟨target⟩ by ⟨date⟩ Objective 5: Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice [source: JFM responsibility (P6)] KR1. From ⟨baseline⟩ to ⟨target⟩ by ⟨date⟩ — tied to: "Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice" KR2. Evidence at this level's decision rights bar: "Sets technical strategy for a major area" — ⟨target⟩ by ⟨date⟩
MBO areas
Key result areas from this level's responsibilities, each with a standard grounded in the canon leveling rubric where one exists.
| Area | Standard | Target | Due |
|---|---|---|---|
| Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability) | Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." | ⟨target⟩ | ⟨date⟩ |
| Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system | Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." | ⟨target⟩ | ⟨date⟩ |
| Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations | Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." | ⟨target⟩ | ⟨date⟩ |
| Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge | Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." | ⟨target⟩ | ⟨date⟩ |
| Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice | Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." | ⟨target⟩ | ⟨date⟩ |
Copy / print as textshow ▾hide ▴
1. Area: Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability) [source: JFM responsibility (P6) — reused, no distinct responsibility content] Standard: Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." Target: ⟨target⟩ Due: ⟨date⟩ 2. Area: Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system [source: JFM responsibility (P6) — reused, no distinct responsibility content] Standard: Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." Target: ⟨target⟩ Due: ⟨date⟩ 3. Area: Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations [source: JFM responsibility (P6) — reused, no distinct responsibility content] Standard: Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." Target: ⟨target⟩ Due: ⟨date⟩ 4. Area: Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge [source: JFM responsibility (P6) — reused, no distinct responsibility content] Standard: Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." Target: ⟨target⟩ Due: ⟨date⟩ 5. Area: Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice [source: JFM responsibility (P6) — reused, no distinct responsibility content] Standard: Consistent with this level's jfm knowledge-application rubric: "Provides field-defining, organization-wide authority over the PV system, quality, and benefit-risk governance under EMA/MHRA QPPV expectations." Target: ⟨target⟩ Due: ⟨date⟩
Scorecard
Only perspectives with real canon backing are shown — no Financial or Customer perspective, since nothing in the canon grounds business-financial or customer measures for a role alone.
Internal process
- "Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability)"→ ⟨target⟩ by ⟨date⟩
- "Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system"→ ⟨target⟩ by ⟨date⟩
- "Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations"→ ⟨target⟩ by ⟨date⟩
- "Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge"→ ⟨target⟩ by ⟨date⟩
- "Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice"→ ⟨target⟩ by ⟨date⟩
Role calibration
- Meets the scope bar: "Organization-wide architecture and the hardest problems"→ ⟨target⟩ by ⟨date⟩
- Meets the autonomy bar: "Defines direction; minimal oversight"→ ⟨target⟩ by ⟨date⟩
- Meets the complexity bar: "Strategic, open-ended problems shaping the technical future"→ ⟨target⟩ by ⟨date⟩
- Meets the impact bar: "Organization-wide"→ ⟨target⟩ by ⟨date⟩
- Meets the decision rights bar: "Sets technical strategy for a major area"→ ⟨target⟩ by ⟨date⟩
- Meets the leadership bar: "Recognized authority; multiplies many teams"→ ⟨target⟩ by ⟨date⟩
Copy / print as textshow ▾hide ▴
Internal process - "Ensures the marketing authorization holder's PV system is robust, compliant, and continuously improving across all products and therapeutic areas (QPPV-level accountability)" → ⟨target⟩ by ⟨date⟩ [source: JFM responsibility (P6)] - "Serves as the regulatory single point of contact for EMA and national competent authorities, available 24/7, retaining ultimate non-transferable accountability for the PV system" → ⟨target⟩ by ⟨date⟩ [source: JFM responsibility (P6)] - "Supervises the entire quality system applied to pharmacovigilance, ensuring SOPs, staff training, data quality, and ICSR submission timelines meet regulatory expectations" → ⟨target⟩ by ⟨date⟩ [source: JFM responsibility (P6)] - "Maintains comprehensive overview of products' safety and benefit-risk profiles and leads reassessment and escalation when significant new risks emerge" → ⟨target⟩ by ⟨date⟩ [source: JFM responsibility (P6)] - "Provides organization-wide medical and scientific leadership in drug safety and risk management strategy, mentoring senior PV scientists and influencing industry practice" → ⟨target⟩ by ⟨date⟩ [source: JFM responsibility (P6)] Role calibration - Meets the scope bar: "Organization-wide architecture and the hardest problems" → ⟨target⟩ by ⟨date⟩ [source: level dimension (Scope)] - Meets the autonomy bar: "Defines direction; minimal oversight" → ⟨target⟩ by ⟨date⟩ [source: level dimension (Autonomy)] - Meets the complexity bar: "Strategic, open-ended problems shaping the technical future" → ⟨target⟩ by ⟨date⟩ [source: level dimension (Complexity)] - Meets the impact bar: "Organization-wide" → ⟨target⟩ by ⟨date⟩ [source: level dimension (Impact)] - Meets the decision rights bar: "Sets technical strategy for a major area" → ⟨target⟩ by ⟨date⟩ [source: level dimension (Decision rights)] - Meets the leadership bar: "Recognized authority; multiplies many teams" → ⟨target⟩ by ⟨date⟩ [source: level dimension (Leadership)]